Xiaodong Zhu

Fudan University - Department of Medical Oncology

Shanghai, 20032

China

Fudan University - Department of Oncology

China

SCHOLARLY PAPERS

2

DOWNLOADS

146

TOTAL CITATIONS

2

Scholarly Papers (2)

1.

Phase III Trial Comparing XELOX Regimen (Oxaliplatin Plus Capecitabine) Versus EOX Regimen (Epirubicin, Oxaliplatin and Capecitabine) as First-Line Treatment for Advanced Gastric Cancer: The EXELOX Trial

Number of pages: 27 Posted: 28 Jun 2021
Fudan University - Department of Medical Oncology, Fudan University - Department of Medical Oncology, Shanxi Cancer Hospital, Fudan University - Department of Medical Oncology, Fudan University - Department of Medical Oncology, University of Science and Technology of China (USTC) - Division of Life Science and Medicine, Fudan University - Department of Medical Oncology, Fudan University - Department of Medical Oncology, Fudan University - Department of Medical Oncology, Fudan University - Department of Medical Oncology, Chinese Academy of Sciences (CAS) - Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Soochow University - The First People’s Hospital of Changzhou, Nantong Tumor Hospital, Zhengzhou University - Department of Oncology, Fudan University - School of Public Health, Department of Biostatics, Fudan University - Department of Medical Oncology, Fudan University - Department of Medical Oncology, Fudan University - Department of Medical Oncology, Fudan University - Department of Medical Oncology, Fudan University - Department of Medical Oncology, Fudan University - Department of Medical Oncology, Fudan University - Department of Medical Oncology, Fudan University - Department of Medical Oncology, Shanxi Cancer Hospital, University of Science and Technology of China (USTC) - Division of Life Science and Medicine, Shanxi Cancer Hospital, Fudan University - Department of Medical Oncology, Fudan University - Department of Medical Oncology, Zhengzhou University - Department of Oncology, Chinese Academy of Sciences (CAS) - Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Soochow University - The First People’s Hospital of Changzhou, Nantong Tumor Hospital, Shanxi Cancer Hospital and Fudan University - Department of Medical Oncology
Downloads 115 (527,212)
Citation 2

Abstract:

Loading...

2.

Severe Loss of Visceral Fat and Skeletal Muscle After Chemotherapy Predict Poor Prognosis in Metastatic Gastric Cancer Patients Without Gastrectomy

Number of pages: 24 Posted: 23 May 2019
Fudan University - Department of Medical Oncology, Fudan University - Department of Medical Oncology, Fudan University - Department of Medical Oncology, Fudan University - Department of Medical Oncology, Fudan University - Department of Medical Oncology, Fudan University - Department of Medical Oncology, Fudan University - Department of Medical Oncology, affiliation not provided to SSRN, Fudan University - Department of Oncology and Fudan University - Department of Medical Oncology
Downloads 31 (1,042,673)

Abstract:

Loading...

Visceral fat, Skeletal muscle, Metastatic gastric cancer, chemotherapy, prognosis